What is TB risk assessment AI SaaS in India?

It is a cloud-based software platform that uses machine learning to analyze epidemiological data and identify high-risk TB villages, vulnerable populations (sanitation workers, gig workers), and enables rapid microplanning for TB Mukt Bharat Abhiyaan campaigns. The platform integrates with NIKSHAY (India's TB case tracking system) and state health databases to predict disease clusters and optimize resource allocation.

How much does it cost to start TB risk assessment SaaS in India?

MVP startup cost: ₹40–60 Lakh. Breakdown: AI/ML development (₹15 Lakh), healthcare expert (₹8 Lakh), cloud & security (₹10 Lakh), compliance/regulatory (₹5 Lakh), go-to-market (₹7 Lakh). Full-scale launch with team and marketing: ₹1.5–2 Cr.

Is TB risk assessment SaaS profitable in India?

Yes. Projected year-1 revenue: ₹3–5 Cr from 10–15 district pilots. Year-3 revenue: ₹25–50 Cr at 25–30 state-level deployments. 60% gross margins typical for SaaS. Market timing is strong: government is mandating AI-based microplanning under NTEP; no dominant player exists; ₹2,500+ Cr healthtech TAM in India.

What regulations apply to TB risk assessment SaaS in India?

Key regulations: National TB Elimination Program (NTEP) data governance; NIKSHAY integration approval from Ministry of Health; ISO 27001 (information security); HIPAA-equivalent data protection; GST 5% on SaaS; IEC 62304 (medical device software); NMC Telehealth Guidelines 2022 if offering remote counseling modules. State data residency laws also apply.

TB Risk Assessment SaaS Platform India 2026 — Business

AI SummaryTB risk assessment AI SaaS is a software platform enabling Indian state governments to rapidly identify high-risk TB villages and vulnerable populations using machine learning. With India's 100-day TB Mukt Bharat Abhiyaan targeting 1.58 lakh villages and a public health tech market valued at ₹2,500+ Cr in 2026, the timing is optimal for SaaS founders to build NIKSHAY-integrated solutions. State health departments and district TB centers are actively seeking AI-powered microplanning tools; founders with healthcare domain expertise and cloud engineering can capture ₹25–50 Cr revenue by year 3 through annual licensing to 25–30 states.